Selected research
Market Outlook & Growth Opportunities
Global Clinical Trial Temperature Control Logistics Market Outlook and Growth Opportunities 2026
Market perspective
The global Clinical Trial Temperature Control Logistics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Clinical Trial Temperature Control Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Clinical Trial Temperature Control Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Clinical Trial Temperature Control Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Clinical Trial Temperature Control Logistics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Clinical Trial Temperature Control Logistics market include Cencora, Thermo Fisher Scientific, UPS, Catalent Pharma Solutions, Almac Group, Parexel International, DHL, McKesson and Kuehne+Nagel, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Clinical Trial Temperature Control Logistics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Clinical Trial Temperature Control Logistics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Clinical Trial Temperature Control Logistics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Clinical Trial Temperature Control Logistics market.
Clinical Trial Temperature Control Logistics Segment by Company
Cencora
Thermo Fisher Scientific
UPS
Catalent Pharma Solutions
Almac Group
Parexel International
DHL
McKesson
Kuehne+Nagel
FedEx
UDG Healthcare
PCI Services
Marken
Oximio
Alcura
Klifo A/S.
Walden Group
Bilcare Limited
Biocair
Royale International
Inceptua Group
SEKO MedTec
Clinical Trial Temperature Control Logistics Segment by Type
Warehousing
Transportation and Distribution
Packaging
Others
Clinical Trial Temperature Control Logistics Segment by Application
Phase I
Phase II
Phase III
Phase IV
Clinical Trial Temperature Control Logistics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Clinical Trial Temperature Control Logistics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Clinical Trial Temperature Control Logistics key companies, revenue, market share, and recent developments.
3. To split the Clinical Trial Temperature Control Logistics breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Clinical Trial Temperature Control Logistics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Clinical Trial Temperature Control Logistics significant trends, drivers, influence factors in global and regions.
6. To analyze Clinical Trial Temperature Control Logistics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trial Temperature Control Logistics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clinical Trial Temperature Control Logistics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trial Temperature Control Logistics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Clinical Trial Temperature Control Logistics industry.
Chapter 3: Detailed analysis of Clinical Trial Temperature Control Logistics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Clinical Trial Temperature Control Logistics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Clinical Trial Temperature Control Logistics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Warehousing
- Transportation and Distribution
- Packaging
- Others
Applications
- Phase I
- Phase II
- Phase III
- Phase IV
Companies covered
- Cencora
- Thermo Fisher Scientific
- UPS
- Catalent Pharma Solutions
- Almac Group
- Parexel International
- DHL
- McKesson
- Kuehne+Nagel
- FedEx
- UDG Healthcare
- PCI Services
- Marken
- Oximio
- Alcura
- Klifo A/S.
- Walden Group
- Bilcare Limited
- Biocair
- Royale International
- Inceptua Group
- SEKO MedTec
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Clinical Trial Temperature Control Logistics Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Clinical Trial Temperature Control Logistics Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Clinical Trial Temperature Control Logistics Market Dynamics
- 2.1 Clinical Trial Temperature Control Logistics Industry Trends
- 2.2 Clinical Trial Temperature Control Logistics Industry Drivers
- 2.3 Clinical Trial Temperature Control Logistics Industry Opportunities and Challenges
- 2.4 Clinical Trial Temperature Control Logistics Industry Restraints
3 Clinical Trial Temperature Control Logistics Market by Company
- 3.1 Global Clinical Trial Temperature Control Logistics Company Revenue Ranking in 2025
- 3.2 Global Clinical Trial Temperature Control Logistics Revenue by Company (2021-2026)
- 3.3 Global Clinical Trial Temperature Control Logistics Company Ranking (2024-2026)
- 3.4 Global Clinical Trial Temperature Control Logistics Company Manufacturing Base and Headquarters
- 3.5 Global Clinical Trial Temperature Control Logistics Company Product Type and Application
- 3.6 Global Clinical Trial Temperature Control Logistics Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Clinical Trial Temperature Control Logistics Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Clinical Trial Temperature Control Logistics Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Clinical Trial Temperature Control Logistics Market by Type
- 4.1 Clinical Trial Temperature Control Logistics Type Introduction
- 4.1.1 Warehousing
- 4.1.2 Transportation and Distribution
- 4.1.3 Packaging
- 4.1.4 Others
- 4.2 Global Clinical Trial Temperature Control Logistics Sales Value by Type
- 4.2.1 Global Clinical Trial Temperature Control Logistics Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Clinical Trial Temperature Control Logistics Sales Value by Type (2021-2032)
- 4.2.3 Global Clinical Trial Temperature Control Logistics Sales Value Share by Type (2021-2032)
5 Clinical Trial Temperature Control Logistics Market by Application
- 5.1 Clinical Trial Temperature Control Logistics Application Introduction
- 5.1.1 Phase I
- 5.1.2 Phase II
- 5.1.3 Phase III
- 5.1.4 Phase IV
- 5.2 Global Clinical Trial Temperature Control Logistics Sales Value by Application
- 5.2.1 Global Clinical Trial Temperature Control Logistics Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Clinical Trial Temperature Control Logistics Sales Value by Application (2021-2032)
- 5.2.3 Global Clinical Trial Temperature Control Logistics Sales Value Share by Application (2021-2032)
6 Clinical Trial Temperature Control Logistics Regional Value Analysis
- 6.1 Global Clinical Trial Temperature Control Logistics Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Clinical Trial Temperature Control Logistics Sales Value by Region (2021-2032)
- 6.2.1 Global Clinical Trial Temperature Control Logistics Sales Value by Region: 2021-2026
- 6.2.2 Global Clinical Trial Temperature Control Logistics Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Clinical Trial Temperature Control Logistics Sales Value (2021-2032)
- 6.3.2 North America Clinical Trial Temperature Control Logistics Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Clinical Trial Temperature Control Logistics Sales Value (2021-2032)
- 6.4.2 Europe Clinical Trial Temperature Control Logistics Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Clinical Trial Temperature Control Logistics Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Clinical Trial Temperature Control Logistics Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Clinical Trial Temperature Control Logistics Sales Value (2021-2032)
- 6.6.2 South America Clinical Trial Temperature Control Logistics Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Clinical Trial Temperature Control Logistics Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Clinical Trial Temperature Control Logistics Sales Value Share by Country, 2025 VS 2032
7 Clinical Trial Temperature Control Logistics Country-level Value Analysis
- 7.1 Global Clinical Trial Temperature Control Logistics Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Clinical Trial Temperature Control Logistics Sales Value by Country (2021-2032)
- 7.2.1 Global Clinical Trial Temperature Control Logistics Sales Value by Country (2021-2026)
- 7.2.2 Global Clinical Trial Temperature Control Logistics Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.7.2 France Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.14.2 China Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.17.2 India Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Clinical Trial Temperature Control Logistics Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Clinical Trial Temperature Control Logistics Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Clinical Trial Temperature Control Logistics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Cencora
- 8.1.1 Cencora Company Information
- 8.1.2 Cencora Business Overview
- 8.1.3 Cencora Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.1.4 Cencora Clinical Trial Temperature Control Logistics Product Portfolio
- 8.1.5 Cencora Recent Developments
- 8.2 Thermo Fisher Scientific
- 8.2.1 Thermo Fisher Scientific Company Information
- 8.2.2 Thermo Fisher Scientific Business Overview
- 8.2.3 Thermo Fisher Scientific Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Scientific Clinical Trial Temperature Control Logistics Product Portfolio
- 8.2.5 Thermo Fisher Scientific Recent Developments
- 8.3 UPS
- 8.3.1 UPS Company Information
- 8.3.2 UPS Business Overview
- 8.3.3 UPS Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.3.4 UPS Clinical Trial Temperature Control Logistics Product Portfolio
- 8.3.5 UPS Recent Developments
- 8.4 Catalent Pharma Solutions
- 8.4.1 Catalent Pharma Solutions Company Information
- 8.4.2 Catalent Pharma Solutions Business Overview
- 8.4.3 Catalent Pharma Solutions Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.4.4 Catalent Pharma Solutions Clinical Trial Temperature Control Logistics Product Portfolio
- 8.4.5 Catalent Pharma Solutions Recent Developments
- 8.5 Almac Group
- 8.5.1 Almac Group Company Information
- 8.5.2 Almac Group Business Overview
- 8.5.3 Almac Group Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.5.4 Almac Group Clinical Trial Temperature Control Logistics Product Portfolio
- 8.5.5 Almac Group Recent Developments
- 8.6 Parexel International
- 8.6.1 Parexel International Company Information
- 8.6.2 Parexel International Business Overview
- 8.6.3 Parexel International Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.6.4 Parexel International Clinical Trial Temperature Control Logistics Product Portfolio
- 8.6.5 Parexel International Recent Developments
- 8.7 DHL
- 8.7.1 DHL Company Information
- 8.7.2 DHL Business Overview
- 8.7.3 DHL Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.7.4 DHL Clinical Trial Temperature Control Logistics Product Portfolio
- 8.7.5 DHL Recent Developments
- 8.8 McKesson
- 8.8.1 McKesson Company Information
- 8.8.2 McKesson Business Overview
- 8.8.3 McKesson Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.8.4 McKesson Clinical Trial Temperature Control Logistics Product Portfolio
- 8.8.5 McKesson Recent Developments
- 8.9 Kuehne+Nagel
- 8.9.1 Kuehne+Nagel Company Information
- 8.9.2 Kuehne+Nagel Business Overview
- 8.9.3 Kuehne+Nagel Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.9.4 Kuehne+Nagel Clinical Trial Temperature Control Logistics Product Portfolio
- 8.9.5 Kuehne+Nagel Recent Developments
- 8.10 FedEx
- 8.10.1 FedEx Company Information
- 8.10.2 FedEx Business Overview
- 8.10.3 FedEx Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.10.4 FedEx Clinical Trial Temperature Control Logistics Product Portfolio
- 8.10.5 FedEx Recent Developments
- 8.11 UDG Healthcare
- 8.11.1 UDG Healthcare Company Information
- 8.11.2 UDG Healthcare Business Overview
- 8.11.3 UDG Healthcare Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.11.4 UDG Healthcare Clinical Trial Temperature Control Logistics Product Portfolio
- 8.11.5 UDG Healthcare Recent Developments
- 8.12 PCI Services
- 8.12.1 PCI Services Company Information
- 8.12.2 PCI Services Business Overview
- 8.12.3 PCI Services Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.12.4 PCI Services Clinical Trial Temperature Control Logistics Product Portfolio
- 8.12.5 PCI Services Recent Developments
- 8.13 Marken
- 8.13.1 Marken Company Information
- 8.13.2 Marken Business Overview
- 8.13.3 Marken Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.13.4 Marken Clinical Trial Temperature Control Logistics Product Portfolio
- 8.13.5 Marken Recent Developments
- 8.14 Oximio
- 8.14.1 Oximio Company Information
- 8.14.2 Oximio Business Overview
- 8.14.3 Oximio Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.14.4 Oximio Clinical Trial Temperature Control Logistics Product Portfolio
- 8.14.5 Oximio Recent Developments
- 8.15 Alcura
- 8.15.1 Alcura Company Information
- 8.15.2 Alcura Business Overview
- 8.15.3 Alcura Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.15.4 Alcura Clinical Trial Temperature Control Logistics Product Portfolio
- 8.15.5 Alcura Recent Developments
- 8.16 Klifo A/S.
- 8.16.1 Klifo A/S. Company Information
- 8.16.2 Klifo A/S. Business Overview
- 8.16.3 Klifo A/S. Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.16.4 Klifo A/S. Clinical Trial Temperature Control Logistics Product Portfolio
- 8.16.5 Klifo A/S. Recent Developments
- 8.17 Walden Group
- 8.17.1 Walden Group Company Information
- 8.17.2 Walden Group Business Overview
- 8.17.3 Walden Group Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.17.4 Walden Group Clinical Trial Temperature Control Logistics Product Portfolio
- 8.17.5 Walden Group Recent Developments
- 8.18 Bilcare Limited
- 8.18.1 Bilcare Limited Company Information
- 8.18.2 Bilcare Limited Business Overview
- 8.18.3 Bilcare Limited Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.18.4 Bilcare Limited Clinical Trial Temperature Control Logistics Product Portfolio
- 8.18.5 Bilcare Limited Recent Developments
- 8.19 Biocair
- 8.19.1 Biocair Company Information
- 8.19.2 Biocair Business Overview
- 8.19.3 Biocair Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.19.4 Biocair Clinical Trial Temperature Control Logistics Product Portfolio
- 8.19.5 Biocair Recent Developments
- 8.20 Royale International
- 8.20.1 Royale International Company Information
- 8.20.2 Royale International Business Overview
- 8.20.3 Royale International Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.20.4 Royale International Clinical Trial Temperature Control Logistics Product Portfolio
- 8.20.5 Royale International Recent Developments
- 8.21 Inceptua Group
- 8.21.1 Inceptua Group Company Information
- 8.21.2 Inceptua Group Business Overview
- 8.21.3 Inceptua Group Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.21.4 Inceptua Group Clinical Trial Temperature Control Logistics Product Portfolio
- 8.21.5 Inceptua Group Recent Developments
- 8.22 SEKO MedTec
- 8.22.1 SEKO MedTec Company Information
- 8.22.2 SEKO MedTec Business Overview
- 8.22.3 SEKO MedTec Clinical Trial Temperature Control Logistics Revenue and Gross Margin (2021-2026)
- 8.22.4 SEKO MedTec Clinical Trial Temperature Control Logistics Product Portfolio
- 8.22.5 SEKO MedTec Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst